Investors
Share price
{{priceData.date}} {{priceData.time}}
{{'2023-03-24T15:28:48Z' | dateFormatFilter}}
Oral semaglutide 25 mg and 50 mg demonstrate superior reductions in HbA1c and body weight versus 14 mg in people with type 2 diabetes in the PIONEER PLUS phase 3 trial
Read more
{{'2023-03-23T15:16:17Z' | dateFormatFilter}}
Resolutions from the Annual General Meeting of Novo Nordisk A/S
Read more
{{'2023-03-07T11:00:38Z' | dateFormatFilter}}
Novo Nordisk announces changes in Executive Management
Read more
Here are our current job openings. If there is not a job you are looking for, you are welcome to create a job agent or a candidate profile.